Cargando…
Pharmacokinetics of meropenem in critically ill patients in Saudi Arabia
BACKGROUND: Meropenem is commonly used in the ICU to treat gram-negative infections. Due to various pathophysiological changes, critically ill patients are at higher risk of having subtherapeutic concentrations and hence have a higher risk of treatment failure—especially in regions where gram-negati...
Autores principales: | Alsultan, Abdullah, Dasuqi, Shereen A., Aljamaan, Fadi, Omran, Rasha A., Syed, Saeed Ali, AlJaloud, Turki, AlAhmadi, Abdullah, Alqahtani, Saeed, Hamad, Mohammed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596159/ https://www.ncbi.nlm.nih.gov/pubmed/34819789 http://dx.doi.org/10.1016/j.jsps.2021.09.017 |
Ejemplares similares
-
Assessment of anti-factor Xa activity in critically ill COVID-19 patients receiving three different anticoagulation regimens
por: Hamad, Mohammed A, et al.
Publicado: (2021) -
Monkeypox Disease (MPOX) Perceptions among Healthcare Workers versus General Population during the First Month of the WHO Alert: Cross-Sectional Survey in Saudi Arabia
por: Temsah, Mohamad-Hani, et al.
Publicado: (2022) -
Clinical pharmacology applications in clinical drug development and clinical care: A focus on Saudi Arabia
por: Alsultan, Abdullah, et al.
Publicado: (2020) -
Exploring the value of a Doctor of Philosophy program in Pharmaceutical Outcomes and Policy Research in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2020) -
Clinical pharmacokinetics of capecitabine and its metabolites in colorectal cancer patients
por: Alqahtani, Saeed, et al.
Publicado: (2022)